
This activity includes a Powered by Patients interview.
This activity was originally broadcast live at PTCE and Asembia Specialty Pharmacy Day of Education 2023.
Program Description
Retinal diseases including neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) pose a significant burden to patients and the health care system. In addition to time requirements for appointments for intravitreal injections of anti-vascular endothelial growth factor (VEGF) inhibitors and post-injection recovery, the cost of anti-VEGF therapies may limit patient access as well. Managed care professionals and pharmacists must ensure that retinal specialists and patients have access to a variety of anti-VEGF therapies so that treatment can be individualized. Specialty pharmacists are in a unique position to offer patient counseling expertise to patients on their retinal injections and provide an additional layer of ongoing treatment monitoring. This program will review the differentiating factors of available anti-VEGF therapies for nAMD and DME and emerging agents to equip pharmacists to ensure appropriate communication occurs with retinal specialists so that patients receive timely, effective, and comprehensive treatment. An included interview with a patient with nAMD/DME will shed light on the challenges in treatment and quality of life as well as their experience with medication access through collaboration with pharmacists involved in their care.
Target Audience: Specialty Pharmacist
Type of Activity: Application
Release date: October 17, 2023
Expiration date: October 17, 2024
Learner level: Foundational and intermediate
Time to complete activity: 1.5 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Analyze the disease burden of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) and the impact on patient quality of life
- Explain the mechanism of action, pharmacokinetics, and efficacy of anti-vascular endothelial growth factor (VEGF) agents in the treatment of nAMD and DME
- Examine current clinical guidelines and recommendations for the use of anti-VEGF therapies in nAMD and DME
- Identify opportunities for pharmacists to collaborate with other health care providers to improve access to care for patients with nAMD and DME, including addressing barriers to care such as cost, transportation, and lack of access to specialty providers

John Mollick, PharmD, MBA
Specialty Pharmacist
CVS Specialty Pharmacy
Pittsburgh, Pennsylvania

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-23-398-H01-P. The activity is available for CE credit through October 17, 2024.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
John Mollick, PharmD, MBA
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Namissa-Buszka, PharmD, BCPS, CHCP; Michelle C. Carlson, PharmD; Kylie Ferrentino; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
